… most anticipating in 2013. With your help, we’ll continue to work hard to drive forward progress to find new drugs for … we’ve entered into never-before-seen collaborations with companies like Sanofi , and launched a successful Partnering … director of research partnerships “It’s encouraging how many Parkinson’s disease-related projects are now in …

… Vanderbilt–Bristol-Myers Squibb collaboration leveraging MJFF investment … a specific glutamate receptor called mGluR4. “The long-term commitment of and collaboration with MJFF were critical to … Todd Sherer , PhD, CEO of MJFF. “It’s the latest example of how de-risking speeds promising treatments toward clinical …

… suggests that neuroinflammation is an important contributor. In this study, we will use pre-clinical models of PD to … models of PD that have significant inflammatory components. Existing drugs/compounds that target the … of Parkinson's disease: In one or two sentences, explain how the project holds potential to impact the way …

… Shelley Gilbert, yoga isn’t just a practice — it’s a way to take action. A Healdsburg, California resident living … Fox — The Michael J. Fox Foundation's (MJFF) grassroots community fundraising program where 100 percent of funds … turned into something much bigger. More than 200 attendees showed up, and with overwhelming community and sponsor …

… As snow falls around our Manhattan office, it's hard to forget the season upon us. The holidays are a wonderful … J. Fox Foundation. Thanks to the generosity of a number of companies and individuals, you can tackle your holiday … GiveNik offers discounted tickets to all of Broadway’s top shows and donates 5 percent of your purchase to the charity …

… Is ignorance bliss when it comes to genetic mutations that may put you at increased risk for … geneticists and genetic counselors their perspective on testing the Ashkenazi-Jewish population for the BRCA 1/2 and …